211 related articles for article (PubMed ID: 15685390)
1. Multiple large-surface photodynamic therapy sessions with topical or systemic aminolevulinic acid and blue light in UV-exposed hairless mice.
Liu Y; Viau G; Bissonnette R
J Cutan Med Surg; 2004; 8(2):131-9. PubMed ID: 15685390
[TBL] [Abstract][Full Text] [Related]
2. Systemic photodynamic therapy with aminolaevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice.
Sharfaei S; Viau G; Lui H; Bouffard D; Bissonnette R
Br J Dermatol; 2001 Jun; 144(6):1207-14. PubMed ID: 11422043
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice.
Stender IM; Bech-Thomsen N; Poulsen T; Wulf HC
Photochem Photobiol; 1997 Oct; 66(4):493-6. PubMed ID: 9337620
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy with topical methyl- and hexylaminolevulinate for prophylaxis and treatment of UV-induced SCC in hairless mice.
Togsverd-Bo K; Lerche CM; Poulsen T; Wulf HC; Haedersdal M
Exp Dermatol; 2010 Aug; 19(8):e166-72. PubMed ID: 20100196
[TBL] [Abstract][Full Text] [Related]
5. Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond.
Bissonette R; Bergeron A; Liu Y
J Drugs Dermatol; 2004; 3(1 Suppl):S26-31. PubMed ID: 14964758
[TBL] [Abstract][Full Text] [Related]
6. Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice.
Sharfaei S; Juzenas P; Moan J; Bissonnette R
Arch Dermatol Res; 2002 Jul; 294(5):237-42. PubMed ID: 12115027
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
Boiy A; Roelandts R; de Witte PA
J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351
[TBL] [Abstract][Full Text] [Related]
8. Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study.
Bay C; Togsverd-Bo K; Lerche CM; Haedersdal M
J Photochem Photobiol B; 2016 Jan; 154():34-9. PubMed ID: 26678673
[TBL] [Abstract][Full Text] [Related]
9. Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice.
van der Veen N; de Bruijn HS; Berg RJ; Star WM
Br J Cancer; 1996 Apr; 73(7):925-30. PubMed ID: 8611408
[TBL] [Abstract][Full Text] [Related]
10. Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous mice.
Caty V; Liu Y; Viau G; Bissonnette R
Br J Dermatol; 2006 Apr; 154(4):740-2. PubMed ID: 16536820
[TBL] [Abstract][Full Text] [Related]
11. Photobleaching during and re-appearance after photodynamic therapy of topical ALA-induced fluorescence in UVB-treated mouse skin.
Van der Veen N; De Bruijn HS; Star WM
Int J Cancer; 1997 Jul; 72(1):110-8. PubMed ID: 9212231
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic and immune effects of 5-aminolevulinic acid photodynamic therapy on UVB-induced squamous cell carcinomas in hairless mice.
Wang H; Li J; Lv T; Tu Q; Huang Z; Wang X
Exp Dermatol; 2013 May; 22(5):362-3. PubMed ID: 23614746
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy using a novel photosensitizer, TONS501, is similarly effective to ALA and EC036 photodynamic therapy on DMBA-and TPA-induced mouse skin papilloma.
Takahashi H; Nakajima S; Asano R; Nakae Y; Sakata I; Iizuka H
J Dermatol Sci; 2012 Jun; 66(3):221-4. PubMed ID: 22464765
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
Schmieder GJ; Huang EY; Jarratt M
J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the chemopreventative effects of ALA PDT in patients with multiple actinic keratoses and a history of skin cancer.
Goldberg LH; Landau JM; Moody MN; Marquez D; Jih M; Kimyai-Asadi A; Friedman PM; Busch A; Vergilis-Kalner IJ
J Drugs Dermatol; 2012 May; 11(5):593-7. PubMed ID: 22527427
[TBL] [Abstract][Full Text] [Related]
16. Aminolevulinic acid (Levulan) in photodynamic therapy of actinic keratoses.
Lang K; Schulte KW; Ruzicka T; Fritsch C
Skin Therapy Lett; 2001 Sep; 6(10):1-2, 5. PubMed ID: 11685275
[TBL] [Abstract][Full Text] [Related]
17. Artificial daylight photodynamic therapy with "non-inflammatory" doses of hexyl aminolevulinate only marginally delays SCC development in UV-exposed hairless mice.
Togsverd-Bo K; Lerche CM; Philipsen PA; Hædersdal M; Wulf HC
Photochem Photobiol Sci; 2013 Dec; 12(12):2130-6. PubMed ID: 24064675
[TBL] [Abstract][Full Text] [Related]
18. Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer.
van den Akker JT; de Bruijn HS; Beijersbergen van Henegouwen GM; Star WM; Sterenborg HJ
Photochem Photobiol; 2000 Sep; 72(3):399-406. PubMed ID: 10989612
[TBL] [Abstract][Full Text] [Related]
19. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
Berman B; Nestor MS; Newburger J; Park H; Swenson N
J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
